Epigenetik ve Bağımlılık Genetiği
Synopsis
This text examines in detail the role of epigenetic mechanisms, which serve as a bridge between the fixed genome and changing environmental conditions, in addiction genetics and forensic sciences. Epigenetics defines dynamic and heritable changes in gene expression that occur through methylation, histone modifications, and non-coding regulatory RNAs without any alterations in the DNA sequence. Substance addiction is a chronic neurological disease resulting from complex interactions of environmental, developmental, and genetic factors, disrupting the balance of dopamine and other neurotransmitters in the brain's mesocorticolimbic reward system. While family, twin, and adoption studies demonstrate the hereditary aspect of addiction, candidate gene and genome-wide analyses reveal genetic susceptibility. The use of legal or illicit substances such as alcohol, opioids, cocaine, nicotine, and methamphetamine shapes neuroplasticity, gene expression, and addictive behaviors by altering histone acetylation and DNA methylation levels in brain regions like the nucleus accumbens, prefrontal cortex, and hippocampus. Single nucleotide polymorphisms in genes such as ADH, OPRM1, CNR1, CHRM2, BDNF, MAOA, and nAChR determine individuals' responses to substances and their risk of addiction. In forensic science, epigenetic profiling offers important and innovative opportunities to determine individuals' biological age, tissue and body fluid sources, ethnic origin, time of death, criminal propensity, and alcohol or drug addiction status without requiring reference comparison DNA material. In the future, it is anticipated that epigenetic studies will find broader application in the forensic justice system and addiction treatment.
References
Ajonijebu, D. C., Abboussi, O., Mabandla, M. V., & Daniels, W. M. (2018). Differential epigenetic changes in the hippocampus and prefrontal cortex of female mice that had free access to cocaine. Metabolic brain disease, 33(2), 411-420.
Berkel, T. D., & Pandey, S. C. (2017). Emerging role of epigenetic mechanisms in alcohol addiction. Alcoholism: Clinical and Experimental Research, 41(4), 666-680.
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., ... & Tischfield, J. A. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proceedings of the National Academy of Sciences, 95(16), 9608-9613.
Bora, G., & Erdem-Yurter, H.(2007). Epigenetik Hastalıklar ve Tedavi Yaklaşımları. Hacettepe Tıp Dergisi, 38, 48-54.
Can, M. İ., & Aslan, A. (2016). Epigenetik Mekanizmalar ve Bazı Güncel Çalışmalar. Karaelmas Science & Engineering Journal, 6(2).
Carolineberry, A., & Berry, R. J. (1967). Epigenetic variation in the human cranium. Journal of anatomy, 101(Pt 2), 361.
Cloninger, C. R., Adolfsson, R., & Svrakic, N. M. (1996). Mapping genes for human personality. Nature genetics, 12(1), 3-4.
Cosci, F., Pistelli, F., Lazzarini, N., & Carrozzi, L. (2011). Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation. Psychology research and behavior management, 4, 119.
Crowley, J. J., Oslin, D. W., Patkar, A. A., Gottheil, E., DeMaria Jr, P. A., O'Brien, C. P., ... & Grice, D. E. (2003). A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric genetics, 13(3), 169-173.
Deşti, R. (2008). Dopamin D3 Ve D4 Reseptör Gen Varyasyonları Ve Madde Bağımlılığı İle İlginin Saptanması. Doktora Tezi, İstanbul.
Desplats, P., Dumaop, W., Cronin, P., Gianella, S., Woods, S., Letendre, S., ... & Grant, I. (2014). Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PloS one, 9(7), e102555.
Dupras, C., Song, L., Saulnier, K. M., & Joly, Y. (2018). Epigenetic discrimination: emerging applications of epigenetics pointing to the limitations of policies against genetic discrimination. Frontiers in genetics, 9, 202.
Ebrahimi, G., Asadikaram, G., Akbari, H., Nematollahi, M. H., Abolhassani, M., Shahabinejad, G., ... & Hashemi, M. (2018). Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. The American journal of drug and alcohol abuse, 44(2), 193-199.
Erson, A. E., & Petty, E. M. (2008). MicroRNAs in development and disease. Clinical genetics, 74(4), 296-306.
Ferri, G., Alu, M., Corradini, B., Picchini, L., Licata, M., Pelotti, S., ... & Beduschi, G. (2009). Genetics of addiction in legal medicine and forensic investigation: SNPs variations associated with nicotine and cannabis dependence. Forensic Science International: Genetics Supplement Series, 2(1), 491-492.
Freeman, W. M., Patel, K. M., Brucklacher, R. M., Lull, M. E., Erwin, M., Morgan, D., ... & Vrana, K. E. (2008). Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology, 33(8), 1807-1817.
Gilbert, S. F. (2001). Ecological developmental biology: developmental biology meets the real world. Developmental biology, 233(1), 1-12. Doi: 10.1006/dbio.2001.0210
Gršković, B., Zrnec, D., Vicković, S., Popović, M., & Mršić, G. (2013). DNA methylation: the future of crime scene investigation?. Molecular biology reports, 40(7), 4349-4360. Doi: 10.1007/s11033-013-2525-3
Gunter, T. D. (2015). Behavioral genetics and the forensic mental health provider: an overview. Behavioral sciences & the law, 33(5), 598-606.
Güleç, G., Köşger F., ve Eşsizoğlu, A. (2015). DSM-5'te Alkol ve Madde Kullanım Bozuklukları. Psikiyatride Güncel Yaklaşımlar, 7(4):448-460.
Gürler, M. (2016). Genetics Factors in Addiction, Acta Medica 47 (2), 47-53
Hamilton, P. J., & Nestler, E. J. (2019). Epigenetics and addiction. Current opinion in neurobiology, 59, 128-136.doi:10.1016/j.conb.2019.05.005
Hawes, N. A., Fidler, A. E., Tremblay, L. A., Pochon, X., Dunphy, B. J., & Smith, K. F. (2018). Understanding the role of DNA methylation in successful biological invasions: a review. Biological Invasions, 20(9), 2285-2300.Doi: 10.1007/s10530-018-1703-6
Hoehe, M. R., Köpke, K., Wendel, B., Rohde, K., Flachmeier, C., Kidd, K. K., ... & Church, G.M. (2000). Sequence variability and candidate gene analysis in complex disease: association of µ opioid receptor gene variation with substance dependence. Human molecular genetics, 9(19), 2895-2908.
https://genomebiology.biomedcentral.com/articles/10.1186/s13059-017-1373-1 Erişim tarihi: 01.11.2020
https://www.whatisepigenetics.com/fundamentals/ erişim tarihi: 01.11.2020
http://www.who.int/tobacco/mpower/mpower_report_tobacco_crisis_2008.pdf Erişim tarihi: 31.10.2020
http://www.yesilay.org.tr/tr/bagimlilik/sigara-ve-tutun-bagimliligi Erişim tarihi: 31.10.2020
Huang, C. J., Liu, H. F., Su, N. Y., Hsu, Y. W., Yang, C. H., Chen, C. C., & Tsai, P. S. (2008). Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia, 63(12), 1288-1295.
Kapur, S., Sharad, S., Singh, R. A., & Gupta, A. K. (2007). A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. Journal of integrative neuroscience, 6(04), 511-522.
Karkowski, L. M., Prescott, C. A., & Kendler, K. S. (2000). Multivariate assessment of factors influencing illicit substance use in twins from female‐female pairs. American journal of medical genetics, 96(5), 665-670.Doi: 10.1002/1096-8628(20001009)96:5<665::AID-AJMG13>3.0.CO;2-O
Karlıkaya, C., Öztuna, F., Solak, Z. A., Özkan, M., & Örsel, O. (2006). Tütün kontrolü. Toraks dergisi, 7(1), 51-64.
Kendler, K. S., Karkowski, L. M., Corey, L. A., Prescott, C. A., & Neale, M. C. (1999). Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women. The British Journal of Psychiatry, 175(4), 351-356. DOI:10.1192/bjp.175.4.351
Kendler, K. S., Karkowski, L. M., Neale, M. C., & Prescott, C. A. (2000). Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Archives of general psychiatry, 57(3), 261-269. doi:10.1001/archpsyc.57.3.261
Kenny, P. J. (2014). Epigenetics, microRNA, and addiction. Dialogues in clinical neuroscience, 16(3), 335.
Kieffer, B. L., & Gavériaux-Ruff, C. (2002). Exploring the opioid system by gene knockout. Progress in neurobiology, 66(5), 285-306.
Knapman, A., & Connor, M. (2015). Cellular signalling of non‐synonymous single-nucleotide polymorphisms of the human μ‐opioid receptor (OPRM 1). British journal of pharmacology, 172(2), 349-363.
Koczor, C. A., Fields, E., Jedrzejczak, M. J., Jiao, Z., Ludaway, T., Russ, R., ... & Lewis, W. (2015). Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression. Toxicology and applied pharmacology, 288(3), 409-419.
Koçak, E., & Aygün, E. (2012). Psikiyatrik Bozukluklar ve Epigenetik. Türk Psikiyatri Dergisi, 23(2), 130-140.
Kozlenkov, A., Jaffe, A. E., Timashpolsky, A., Apontes, P., Rudchenko, S., Barbu, M., ... & Dracheva, S. (2017). DNA methylation profiling of human prefrontal cortex neurons in heroin users shows significant difference between genomic contexts of hyper-and hypomethylation and a younger epigenetic age. Genes, 8(6), 152.
Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278(5335), 45-47.
Maze, I., Feng, J., Wilkinson, M. B., Sun, H., Shen, L., & Nestler, E. J. (2011). Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens. Proceedings of the National Academy of Sciences, 108(7), 3035-3040.
McClung, C.A., & Nestler E.J. (2003). Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci, 6, 1208-15.
McLellan, A. T., Lewis, D. C., O'brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Jama, 284(13), 1689-1695. doi:10.1001/jama.284.13.1689
Métivier, R., Gallais, R., Tiffoche, C., Le Péron, C., Jurkowska, R. Z., Carmouche, R. P., ... & Benes, V. (2008). Cyclical DNA methylation of a transcriptionally active promoter. Nature, 452(7183), 45-50.Doi: 10.1038/nature06544
Mura, E., Govoni, S., Racchi, M., Carossa, V., Ranzani, G. N., Allegri, M., & van Schaik, R. H. (2013). Consequences of the 118A> G polymorphism in the OPRM1 gene: translation from bench to bedside?. Journal of pain research, 6, 331.
Nielsen, D. A., Hamon, S., Yuferov, V., Jackson, C., Ho, A., Ott, J., & Kreek, M. J. (2010). Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Human genetics, 127(6), 639-649.
Park, E. R., Kleimann, S., Youatt, E. J., Lockhart, A., Campbell, E. G., Levy, D. E., ... & Shields, A. E. (2011). Black and White adults' perspectives on the genetics of nicotine addiction susceptibility. Addictive behaviors, 36(7), 769-772. Doi: /10.1016/j.addbeh.2011.02.007
Ponomarev, I., Wang, S., Zhang, L., Harris, R. A., & Mayfield, R. D. (2012). Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. Journal of Neuroscience, 32(5), 1884-1897.
Renthal, W., & Nestler, E. J. (2009). Chromatin regulation in drug addiction and depression. Dialogues in clinical neuroscience, 11(3), 257.
Rotter, A., Bayerlein, K., Hansbauer, M., Weiland, J., Sperling, W., Kornhuber, J., & Biermann, T. (2013). CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. European addiction research, 19(1), 13-20.
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A., ... & Swan, G. E. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human molecular genetics, 16(1), 36-49.
Salehzadeh, S. A., Mohammadian, A., & Salimi, F. (2020). Effect of chronic methamphetamine injection on levels of BDNF mRNA and its CpG island methylation in prefrontal cortex of rats. Asian Journal of Psychiatry, 48, 101884.
Scott, S. A. (2011). Personalizing medicine with clinical pharmacogenetics. Genetics in Medicine, 13(12), 987-995.Doi: 10.1097/GIM.0b013e318238b38c
Shi, J., Hui, L., Xu, Y., Wang, F., Huang, W., & Hu, G. (2002). Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Human mutation, 19(4), 459-460.
Sweatt, J. D. (2009). Experience-dependent epigenetic modifications in the central nervous system. Biological psychiatry, 65(3), 191-197. Doi: 10.1016/j.biopsych.2008.09.002
Teppen, T. L., Krishnan, H. R., Zhang, H., Sakharkar, A. J., & Pandey, S. C. (2016). The potential role of amygdaloid microRNA-494 in alcohol-induced anxiolysis. Biological psychiatry, 80(9), 711-719.
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E.J. (2007). Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci, 8, 355-67.
Verma, M., & Srivastava, S. (2002). Epigenetics in cancer: implications for early detection and prevention. The lancet oncology, 3(12), 755-763. Doi: 10.1016/S1470-2045(02)00932-4
Vidaki, A., & Kayser, M. (2017). From forensic epigenetics to forensic epigenomics: broadening DNA investigative intelligence. Genome biology, 18(1), 238.
Vito, G. F., & Maahs, J. R. (2015). Criminology. Jones & Bartlett Publishers.
Zhang, L., Kendler, K. S., & Chen, X. (2006). The μ-opioid receptor gene and smoking initiation and nicotine dependence. Behavioral and brain functions, 2(1), 28.